Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ashni Naturaceuticals was a private U.S. nutraceutical company focused on the research, development, and marketing of clinically tested and patent-protected nutritional and botanical products. The company appears to have operated around 1999-2002 from Salt Lake City, Utah, and marketed nutraceutical supplements rather than prescription therapeutics. Public records and trade coverage indicate Ashni acquired BioNexus Genomics in 2000 to add genomic, proteomic, and signal-transduction capabilities for the development of functional foods and proprietary dietary supplements. Its intellectual property included supplement formulations and analytical/product-development concepts such as "genomic bioprinting," with patents and trademarks tied to anti-inflammatory and nutritional compositions. Available business registry records suggest the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ashni Naturaceuticals.